Healthcare Facilities and Services (TRBC)
-
Health
Dementia patient over-medicated and bruised when he died, widow tells Australian aged care inquiry
SYDNEY (Reuters) – An elderly man suffering Parkinson’s Disease and dementia was given 10 times his medication and had unexplained…
Read More » -
Health
U.S. government proposes rule overhauling drug industry rebate system
NEW YORK/WASHINGTON (Reuters) – The U.S. government on Thursday proposed a rule to end the industry-wide system of after-market discounts…
Read More » -
Health
Exclusive: Teva’s generic EpiPen launch stalls months after approval
NEW YORK (Reuters) – Many of the largest U.S. pharmacies and drug distributors do not have Teva Pharmaceutical Industries Ltd’s…
Read More » -
Health
U.S. lawmaker Yarmuth says Democrats to begin Medicare for All hearings
WASHINGTON (Reuters) – Democrats in control of the U.S. House of Representatives will begin holding hearings on expanding Medicare this…
Read More » -
Health
Apple Watch, using Aetna client data, wants to help you be healthy
(Reuters) – CVS Health Corp’s health insurer Aetna on Tuesday said it is working with Apple Inc on a new…
Read More » -
Health
Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen
NEW YORK (Reuters) – CVS Health Corp, a top U.S. manager of pharmacy benefits, has added new migraine drugs from…
Read More » -
Health
Aetna, other health insurers team up with IBM on blockchain project
FILE PHOTO: Logos of CVS and Aetna are displayed on a monitor above the floor of the New York Stock…
Read More » -
Health
Not-for-profit to offer 20 generic drugs in 2019 to alleviate shortages
(Reuters) – A new not-for-profit supplier of generic drugs formed by a consortium of hospitals systems said it expects this…
Read More » -
Health
CVS unveils ‘Beauty Marks’ in stores, warning shoppers of edited images
NEW YORK (Reuters) – CVS Pharmacy unveiled an initiative in U.S. stores on Thursday, labeling photos of models in its…
Read More » -
Health
U.S. insulin costs per patient nearly doubled from 2012 to 2016: study
(Reuters) – The cost of insulin for treating type 1 diabetes in the United States nearly doubled over a five-year…
Read More »
